Benzinga’s 2nd Annual Cannabis Capital Conference to Draw Key Players in the Burgeoning Industry

FLORIDA: North America’s leading cannabis entrepreneurs and investors will flock to beautiful Miami, Florida, Jan. 15-16, 2019, for the second annual Cannabis Capital Conference, hosted by premier financial media outlet Benzinga. This highly-anticipated event sets the standard among cannabis conferences, offering unparalleled access and seamless interaction between the entrepreneurs who are establishing highly promising companies and the investors whose capital will fuel their efforts.

Cannabis Capital Conference

Returning to present at the event once again are top investors like CNBC’s Tim Seymour, Jon Najarian and New Cannabis Ventures founder Alan Brochstein. They will speak alongside some of America’s leading CEOs, who are expertly guiding today’s standout cannabis companies to success.

“Benzinga’s Cannabis Capital Conference brings together the crème de la crème of the cannabis world,” said Neal Hamilton, vice president of marketing for Benzinga. “Benzinga has long presided as a financial media leader, offering broad coverage relative to the cannabis space. We now bring that standout expertise to a live setting where entrepreneurs and investors can network, forge deals and learn from today’s top cannabis influencers, policymakers and innovators. No other cannabis conference facilitates the level of access or the seamless interaction between cannabis investors and entrepreneurs that the Cannabis Capital Conference provides.”

Tickets for the Benzinga Cannabis Capital Conference are on sale now and can be purchased online. Investors can qualify for free passes by emailing bzcannabis@benzinga.com.

The Cannabis Capital Conference will kick off Jan. 15 with an exclusive, invitation-only cannabis executive retreat. This C-suite event will be held exclusively for cannabis operators and executives. Discussion topics will include post-legalization Canada, the next steps for legalization in the United States, 280E and more. That evening, a general admission networking event will take place for all conference participants.

On Jan. 16, the Cannabis Capital Conference will get into full swing with a full day of engaging panels, exclusive investor presentations, speed networking and more. The second day represents the perfect opportunity to make deals and learn from policy makers, influencers and trailblazers.

“The Cannabis Industry: Growth Opportunities for Professionals, Operators and Investors” Is October 17th In Boston

MASSACHUSETTS: Burns & Levinson and Viridian Capital Advisors will co-host “The Cannabis Industry: Growth Opportunities for Professionals, Operators and Investors,” an invitation-only event that will explore opportunities within the rapidly growing multi-billion dollar cannabis industry for professional investors and entrepreneurs. The conference will be held on October 17, 2017 from 8:00 a.m. to 6:00 p.m. EDT at the Hilton Boston/Dedham Hotel.

This investor-focused conference is intended to help venture capitalists, private equity firms, and single- and multi-family offices learn more about cannabis investments as an alternative asset class poised to provide non-correlative returns to many other types of investments.  As legalization continues to spread, cannabis is opening new doors in traditional markets – biotech/pharma, real estate, software, consumer packaged goods and branded products, among others – long favored by institutional investors.

The event will feature four in-depth panel discussions, networking opportunities, and a keynote speech by Kris Krane, co-founder and managing partner of 4Front Advisors and president of 4Front Ventures. Krane helped draft Massachusetts Ballot Question 4 – Legalize Marijuana in the 2016 election, and prior to forming 4Front, he served as director of client services for CannBe, which was a pioneer in developing best practices within the marijuana industry. Krane will discuss future opportunities and risks in the marijuana industry in New England and across the country.

“We believe this is the first conference in New England with a specific focus on institutional investing in the cannabis industry,” said Frank A. Segall, co-chair of the Cannabis Business Advisory Group at Burns & Levinson. “Cannabis is already a multi-billion dollar industry, and its growth is projected to potentially increase at an exponential and possibly unprecedented rate over the coming years.”

“There are many promising cannabis industry sectors that are poised for significant growth and return on investment. We want to help the investment community understand the risks and rewards, and give them the tools they need to take advantage of these opportunities,” added Scott Moskol, who co-chairs Burns’ Cannabis Business Advisory Group with Segall.

Specific breakout sessions will include: 

The New England Experience – A discussion on how cannabis business operators across New England have navigated the sometimes tempestuous legal waters to build successful businesses including raising capital and investments.

Follow the Money: Analyzing Capital Flow into the Legal Cannabis Industry – A look at the capital infusions necessary to launch, operate, or invest in the cannabis space, with Viridian providing deal-data insight regarding capital raises and M&A activity.

Sector Focus: Cannabinoid-Based Biopharmaceuticals and Personalized Medicine – A deep dive into the research, development, and commercialization of cannabis-based pharmaceuticals, an industry sub-sector that could hold the greatest potential value over time.

The Future of Cannabis – A critical review of key legal and regulatory changes on the horizon and the expected impact for investors and capital providers.